NEVVI Medicare utilization intelligence
or

← back

Provider profile

ALBRECHT, PEGGY M.D.

Dermatology · NPI 1023097383 · SOQUEL, CA

1
Groups
25
Codes · 2024
6,112
Disclosed services

ALBRECHT, PEGGY is a Dermatology in SOQUEL, CA, a member of 1 medical group, who billed 25 distinct codes to Medicare Part B in 2024.

Groups: SUTTER BAY MEDICAL FOUNDATION (PALO ALTO, CA)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

6,112
disclosed services
25
codes billed to Medicare Part B
Prior year · CY2023 6,876 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
17003 Destruction of precancer skin growth, 2-14 growths
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
17110 Destruction of skin growth, 1-14 growths
17000 Destruction of precancer skin growth, 1 growth
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
11102 Biopsy of related skin growth, first growth
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
17004 Destruction of precancer skin growth, 15 or more growths
17261 Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm
11301 Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
11103 Biopsy of related skin growth, each additional growth
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm
11310 Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
10060 Simple or single drainage of skin abscess
11900 Injection into skin growth, 1-7 growths
17271 Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm
11300 Shaving of skin growth of body, arms, or legs, 0.5 cm or less
96567 Application of light to destroy precancer skin growth
11305 Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less
11306 Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm
17111 Destruction of skin growth, 15 or more growths
11311 Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm
69100 Biopsy of ear

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.